On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Motor Neurone Disease Association's own share of each project, not the project's full budget.
- Horizon 2020€37k · 2 projects
Projects
2 EU-funded projects, newest first. Each links to the official record.
- TUDCA-ALSPartner
Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)
Horizon 2020 · 2018–2023 · Project on CORDIS ↗
€37ktheir share - MIROCALSPartner
Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
Horizon 2020 · 2015–2021 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The University of SheffieldUnited Kingdom · 2 shared projects
- Humanitas Mirasole SpAItaly · 2 shared projects
- Katholieke Universiteit LeuvenBelgium · 1 shared project
- King'S College LondonUnited Kingdom · 1 shared project
- The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinIreland · 1 shared project
- Universitair Medisch Centrum UtrechtNetherlands · 1 shared project
- Goeteborgs UniversitetSweden · 1 shared project
- Queen Mary University of LondonUnited Kingdom · 1 shared project
- Universitaet UlmGermany · 1 shared project
- The University of SussexUnited Kingdom · 1 shared project
- Istituto Superiore di SanitaItaly · 1 shared project
- Inserm Transfert SAFrance · 1 shared project
- Association GenethonFrance · 1 shared project
- Centre Hospitalier Regional Universitaire de ToursFrance · 1 shared project
- Icon Clinical Research LimitedIreland · 1 shared project
- Centre Hospitalier UniversitaireFrance · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- amyotrophic lateral sclerosis
- diabetes
- drug discovery
- graft versus host disease
- immunology
- pharmaceutical drugs
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.